Annual CFO
$898.40 K
-$3.55 M-79.81%
December 1, 2023
Summary
- As of February 26, 2025, NNNN annual cash flow from operations is $898.40 thousand, with the most recent change of -$3.55 million (-79.81%) on December 1, 2023.
- During the last 3 years, NNNN annual CFO has fallen by -$3.28 million (-78.51%).
Performance
NNNN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NNNN Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -79.8% | - | - |
3 y3 years | -78.5% | - | - |
5 y5 years | -78.5% | - | - |
NNNN Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -79.8% | at low | ||||
5 y | 5-year | -79.8% | at low | ||||
alltime | all time | -79.8% | at low |
Anbio Biotechnology Class A Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $898.40 K(-79.8%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $4.45 M(+6.4%) | - | - |
Dec 2021 | $4.18 M | - | - |
FAQ
- What is Anbio Biotechnology Class A annual cash flow from operations?
- What is the all time high annual CFO for Anbio Biotechnology Class A?
- What is Anbio Biotechnology Class A annual CFO year-on-year change?
What is Anbio Biotechnology Class A annual cash flow from operations?
The current annual CFO of NNNN is $898.40 K
What is the all time high annual CFO for Anbio Biotechnology Class A?
Anbio Biotechnology Class A all-time high annual cash flow from operations is $4.45 M
What is Anbio Biotechnology Class A annual CFO year-on-year change?
Over the past year, NNNN annual cash flow from operations has changed by -$3.55 M (-79.81%)